Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. (Q33403196)

From Wikidata

Revision as of 02:40, 30 November 2021 by Edoderoobot (talk | contribs) (‎Changed label, description and/or aliases in nl: nl-description, python code -)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

title

Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

main subject

atypical hemolytic uremic syndrome

1 reference

based on heuristic

inferred from title

author

Julien Zuber

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

Moglie Le Quintrec

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

author name string

S Krid

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

C Bertoye

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

V Gueutin

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

A Lahoche

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

N Heyne

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

G Ardissino

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

V Chatelet

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

L-H Noël

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

M Hourmant

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

P Niaudet

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

V Frémeaux-Bacchi

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

E Rondeau

series ordinal

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

C Legendre

series ordinal

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

C Loirat

series ordinal

16

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

French Study Group for Atypical HUS

series ordinal

17

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

language of work or name

English

0 references

publication date

7 September 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

published in

American Journal of Transplantation

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

volume

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

page(s)

3337-3354

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

cites work

Atypical hemolytic-uremic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

New insights into postrenal transplant hemolytic uremic syndrome.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Therapeutic potential of complement modulation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Eculizumab: a review of its use in paroxysmal nocturnal haemoglobinuria

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Eculizumab for congenital atypical hemolytic-uremic syndrome.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Complement inhibitor eculizumab in atypical hemolytic uremic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Rescue therapy with eculizumab in a transplant recipient with atypical haemolytic-uraemic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Eculizumab in atypical haemolytic-uraemic syndrome allows cessation of plasma exchange and dialysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Complement Mutation-AssociatedDe NovoThrombotic Microangiopathy Following Kidney Transplantation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Complement activation during liver transplantation-special emphasis on patients with atypical hemolytic uremic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Eculizumab and renal transplantation in a patient with CAPS

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumab.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Pathology after eculizumab in dense deposit disease and C3 GN.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Liver-kidney transplantation to cure atypical hemolytic uremic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Eculizumab for Atypical Hemolytic–Uremic Syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04252.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1600-6143.2012.04252.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

PubMed publication ID

22958221

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22958221

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22958221%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

ResearchGate publication ID

230835636

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33403196&oldid=1536382342"